News
-
-
-
REGULATED PRESS RELEASE
bioMérieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
bioMérieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, expanding sample options for BIOFIRE® SPOTFIRE® R/ST Panel Mini -
-
-
-
REGULATED PRESS RELEASE
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
bioMérieux strengthens next-generation sequencing capabilities with acquisition of Day Zero Diagnostics, enhancing rapid diagnostics & antimicrobial stewardship. Acquisition includes NGS workflows, chemistries & software -
-
-
